COVID-19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors.
Am J Med Genet A
; 182(12): 3068-3070, 2020 12.
Article
en En
| MEDLINE
| ID: mdl-32946196
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Linfangioleiomiomatosis
/
COVID-19
Límite:
Humans
Idioma:
En
Año:
2020
Tipo del documento:
Article